1. Home
  2. MLAB vs PHAT Comparison

MLAB vs PHAT Comparison

Compare MLAB & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$120.91

Market Cap

719.9M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$8.38

Market Cap

759.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
PHAT
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
719.9M
759.7M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
MLAB
PHAT
Price
$120.91
$8.38
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$94.00
$19.83
AVG Volume (30 Days)
134.5K
1.0M
Earning Date
05-27-2026
04-30-2026
Dividend Yield
0.67%
N/A
EPS Growth
436.11
42.72
EPS
0.49
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
$6.07
$93.04
Revenue Next Year
$5.41
$58.91
P/E Ratio
$252.88
N/A
Revenue Growth
N/A
216.93
52 Week Low
$61.42
$8.21
52 Week High
$132.70
$18.31

Technical Indicators

Market Signals
Indicator
MLAB
PHAT
Relative Strength Index (RSI) 55.18 38.84
Support Level $94.20 N/A
Resistance Level N/A $9.74
Average True Range (ATR) 4.22 0.46
MACD -1.03 0.02
Stochastic Oscillator 23.48 9.03

Price Performance

Historical Comparison
MLAB
PHAT

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: